The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The GERMELATOX-A (Dermatologic Cooperative Oncology Group): Study attitude of German melanoma patients towards toxicity during adjuvant treatment.
 
Katharina C. Kähler
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Roche
 
Svea Hüning
Honoraria - Bristol Myers Squibb
Consulting or Advisory Role - Kyowa Kirin; MSD; Sun Pharma
Travel, Accommodations, Expenses - Pierre Fabre
 
Dorothée Nashan
No Relationships to Disclose
 
Frank Meiss
Honoraria - Bristol-Myers Squibb; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pierre Fabre; Roche Pharma AG; Sanofi Aventis GmbH
Speakers' Bureau - Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre
 
David A Rafei-Shamsabadi
Honoraria - Bristol-Myers Squibb/Sanofi; Pierre Fabre; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi; Pierre Fabre
Research Funding - Sanofi
Travel, Accommodations, Expenses - Novartis; Sanofi/Regeneron; Sun Pharma
 
Hannes Rißmann
No Relationships to Disclose
 
Chiara Colapietro
No Relationships to Disclose
 
Elisabeth Livingstone
Honoraria - Bristol-Myers Squibb; Medac; Novartis; Pierre Fabre; Sanofi; Sun Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medac; Pierre Fabre; Sun Pharma
 
Lara Valeska Maul
No Relationships to Disclose
 
Markus V Heppt
No Relationships to Disclose
 
Jessica Cecile Hassel
Honoraria - Almirall Hermal GmbH; Amgen; Bristol Myers Squibb Foundation; GlaxoSmithKline; MSD; Novartis; Pierre Fabre; Roche Pharma AG; Sanofi; Sun Pharma
Consulting or Advisory Role - MSD; Sanofi Aventis GmbH; Sun Pharma
Research Funding - 4SC (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Idera (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Nektar (Inst); Novartis (Inst); Philogen (Inst); Pierre Fabre (Inst); Regeneron (Inst); Sanofi (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - 4SC
 
Ralf Gutzmer
Honoraria - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron; Sun Pharma
Consulting or Advisory Role - 4SC; Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi; Sun Pharma
Research Funding - Amgen (Inst); Johnson & Johnson (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pierre Fabre; Roche; Sun Pharma
 
Carmen Loquai
Consulting or Advisory Role - Almirall Hermal GmbH (Inst); Biontech (Inst); Bristol-Myers Squibb (Inst); Kyowa Kirin International (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - Almirall Hermal GmbH (Inst); Biontech (Inst); Bristol-Myers Squibb (Inst); Kyowa Kirin International (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Sun Pharma (Inst)
 
Lucie Heinzerling
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; CureVac; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Predictive and soluble prognostic biomarker
 
Michael Max Sachse
Honoraria - Novartis
Consulting or Advisory Role - Sanofi
 
Ann-Sophie Bohne
Travel, Accommodations, Expenses - Bristol-Myers Squibb GmbH & Co. KGaA; Pierre Fabre; Sun Pharma Advanced Research Company
 
Laura Moysig
No Relationships to Disclose
 
Wienke Peters
No Relationships to Disclose
 
Judith Rusch
No Relationships to Disclose
 
Christine Blome
Honoraria - AstraZeneca; Helios Klinik Leisnig; URGO MEDICAL
Research Funding - Almirall (Inst); Amgen (Inst); Bauerfeind (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Helios Klinik Leisnig